|
|
Legal status
Patent expired
| (51) | INT.CL. | C07D 473/04 | (2006.01) |
| A61K 31/437 | (2006.01) | ||
| A61P 3/10 | (2006.01) |
| (11) | Number of the document | 1758905 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05707354.6 |
| Date of filing the European patent application | 2005-02-12 | |
| (97) | Date of publication of the European application | 2007-03-07 |
| (45) | Date of publication and mention of the grant of the patent | 2009-04-29 |
| (46) | Date of publication of the claims translation | 2009-08-25 |
| (86) | Number | PCT/EP2005/001427 |
| Date | 2005-02-12 |
| (87) | Number | WO 2005/085246 |
| Date | 2005-09-15 |
| (30) | Number | Date | Country code |
| 102004008112 | 2004-02-18 | DE | |
| 102004012921 | 2004-03-17 | DE | |
| 102004032263 | 2004-07-03 | DE |
| (72) |
HIMMELSBACH, Frank, DE
LANGKOPF, Elke, DE
ECKHARDT, Matthias, DE
TADAYYON, Mohammad, GB
THOMAS, Leo, DE
|
| (73) |
Boehringer Ingelheim International GmbH,
Binger Strasse 173, 55216 Ingelheim am Rhein,
DE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | 8-[3-Amino-piperidin-1-il]-ksantinas, jo gavimas ir panaudojimas DDP-IV inhibitoriaus formos |
| 8-[3-AMINO-PIPERIDIN-1-YL]-XANTHINE, THE PRODUCTION THEREOF AND THE USE IN THE FORM OF A DDP-IV INHIBITOR |
| Payment date | Validity (years) | Amount | |
| 2024-01-23 | 347.00 EUR |